Buma Pharma SRL
The score of Buma Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2023 → 2025: Equity +282 % Total assets +135 %
Accounts of the company itself (not consolidated).
The full file covers 3 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
Buma Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 05 Aug 2026
- Year ended 31 Dec 2024filed on 30 Aug 2025
- Year ended 31 Dec 2023filed on 30 Aug 2024
Buma Pharma's financial analysis
- Solvency67.3%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of Buma Pharma
Buma Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0803.488.513
- VAT number
- BE0803488513
- Peppol
- Registered · 0208:0803488513 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 03 Jul 2023
- Registered office
- 2610 Antwerp
- Latest accounts
- 2025 · filed on 05 Aug 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
Buma Pharma (SRL) has been based in Antwerp since 2023, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 14,746 € and equity of 38,507 €; its revenue is not published. Its solvency stands at 67.3%, above the median of its sector (44.2%).
Companies similar to Buma Pharma
Companies in the same business, of comparable size and area, outside its group.
- Novafontis Business and other management consultancy activities Liège · balance sheet 131,719 €
- SoBayFRo Retail sale of pharmaceutical products Tournai · balance sheet 54,756 €
- Vangheluwe L. Retail sale of pharmaceutical products Ninove · balance sheet 65,040 €
- Eliam Retail sale of pharmaceutical products Hasselt · balance sheet 122,187 €
- MBV Consult Retail sale of pharmaceutical products Lier · balance sheet 63,750 €
- ACP-Pharma Retail sale of pharmaceutical products Affligem · balance sheet 48,017 €
- Sander Koyen Retail sale of pharmaceutical products Wuustwezel · balance sheet 82,286 €
- Styrax Retail sale of pharmaceutical products Merchtem · balance sheet 37,073 €
Frequently asked questions about Buma Pharma
What is the revenue of Buma Pharma?
Buma Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of Buma Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0803488513 for Buma Pharma, if the company is VAT-registered. Its company number (CBE) is 0803.488.513.
Where is the registered office of Buma Pharma?
According to the CBE register, the registered office of Buma Pharma is in 2610 Antwerp.
What is the equity of Buma Pharma?
At the close of the 2025 financial year, the equity of Buma Pharma amounts to 38,507 €, a solvency of 67.3% of total assets.
Who manages Buma Pharma?
The register lists 1 active mandates at Buma Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of Buma Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →